Pfizer Documents Analysis
UK Children Overrepresented in Post-marketing Adverse Events while the FDA Downplays Myocarditis in 5-Year Pfizer Clinical Trial
The initial release of the Pfizer trials and post-marketing documentation allowed millions of concerned Americans to see what Pfizer did to ensure vaccine safety and efficacy. It gave people worldwide an opportunity to assess their data methods even as Pfizer fought hard to trickle these telling documents out over a …
Dr. Wolf: “They Are Counting Wrong – You Can’t Verify the Data Sets.”
https://rumble.com/embed/vv8zez/?pub=4 Dr. Wolf discusses the falsifying of Pfizer vaccine data sets that is being blamed on a “coding error.” Tens of thousands of individuals that were injured by the vaccine have been wiped from the mainstream’s records and buried beneath paperwork. What happened to these individuals? A team of …
Comparisons Between Pfizer’s EUA, Pfizer’s Cumulative Analysis of Post-Authorization Adverse Event Reports, and New Studies Raises Several New Questions
There was a recent study that was published on January 25, 2022 with data compiled from December 2020 through August 2021. https://jamanetwork.com/journals/jama/fullarticle/2788346 There is a cross over in timeline between that new study and Pfizer’s Cumulative Analysis of Post-Authorization Adverse Event Reports, document 5.3.6. https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf Document 5.3.6 contains data from December 2020 …